Does primaquine prevent relapses in people with Plasmodium vivax malaria? Evidence Update, Malaria Series, July 2007

From:
Department for International Development
Published
1 January 2007
Document Type:
Briefing
Theme:
Health

Abstract

Each Evidence Update is a 2-page summary of a Cochrane Review of healthcare interventions relevant to people in low-income and middle-income countries.

This Evidence Update is adapted from Galappaththy GNL, Omari AAA, Tharyan P. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD004389. DOI: 10.1002/14651858.CD004389.pub2.

Evidence supports the World Health Organization's recommended course of primaquine (15 mg/kg/day for 14 days) plus chloroquine.

Citation

Effective Health Care Alliance Programme Consortium, Liverpool School of Tropical Medicine, Liverpool, UK, pp.2

Does primaquine prevent relapses in people with Plasmodium vivax malaria? Evidence Update, Malaria Series, July 2007

Published 1 January 2007
Contents